Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma

Details for Australian Patent Application No. 2007277144 (hide)

Owner Novartis AG

Inventors Venetsanakos, Eleni; Tan, Nguyen; Heise, Carla; Faure, Michel

Agent Davies Collison Cave

Pub. Number AU-B-2007277144

PCT Pub. Number WO2008/013912

Priority 60/820,756 28.07.06 US

Filing date 26 July 2007

Wipo publication date 31 January 2008

Acceptance publication date 19 January 2012

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/013912 Priority application(s): WO2008/013912

19 January 2012 Application Accepted

  Published as AU-B-2007277144

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007277146-Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

2007277142-Methods for identifying, diagnosing, and predicting survival of lymphomas